Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.41 |
| ▸ | TERT | O14746 | 10/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25391492 | 0.87 | TERT (0.41) | HTR7TERTCCR1ALDH1A1CCR8 | |
| SCHEMBL30570368 | 0.87 | TERT (0.41) | HTR7TERTCCR1ALDH1A1CCR8 | |
| SCHEMBL12640965 | 0.84 | TERT (0.40) | HTR7TERTCCR1 | |
| SCHEMBL10751660 | 0.81 | IDO1 (0.40) | TERTCCR1ALDH1A1TSHRELANE | |
| SCHEMBL29476108 | 0.81 | CCR1 (0.48) | TERTCCR1ALDH1A1CCR8 | |
| SCHEMBL2151538 | 0.81 | CCR1 (0.48) | TERTCCR1ALDH1A1CCR8 | |
| SCHEMBL18259179 | 0.77 | TERT (0.40) | TERTCCR1ALDH1A1 | |
| SCHEMBL14280828 | 0.77 | CCR1 (0.52) | HTR7CCR1ALDH1A1TSHRCCR8 | |
| SCHEMBL30570371 | 0.77 | HSP90AA1 (0.43) | HTR7TERTALDH1A1ELANE | |
| SCHEMBL25390259 | 0.77 | HSP90AA1 (0.43) | HTR7TERTALDH1A1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188106-A1 | SUBSTITUTED IMIDAZO[1,5-A]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-06-12 | — | — | US | disclosed |
| WO-2023172667-A2 | SUBSTITUTED IMIDAZO[1,5-a]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023172667-A2 | SUBSTITUTED IMIDAZO[1,5-a]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230174507-A1 | IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF | METABOMED LTD. (IL) | 2023-06-08 | — | — | US | disclosed |
| US-20230174507-A1 | IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF | METABOMED LTD. (IL) | 2023-06-08 | — | — | US | disclosed |
| WO-2021229571-A1 | IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF | METABOMED LTD (IL) | 2021-11-18 | — | — | WO | disclosed |
| EP-2010550-B1 | POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH PYRIDINO-IMINOPHENOL COMPLEXES | TOTAL RES & TECHNOLOGY FELUY (BE) | 2013-06-19 | — | — | EP | disclosed |
| EP-2010550-B1 | POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH PYRIDINO-IMINOPHENOL COMPLEXES | TOTAL RES & TECHNOLOGY FELUY (BE) | 2013-06-19 | — | — | EP | disclosed |
| US-8399582-B2 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2013-03-19 | — | — | US | disclosed |
| US-8399582-B2 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2013-03-19 | — | — | US | disclosed |
| US-8399582-B2 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2013-03-19 | — | — | US | disclosed |
| US-20100160583-A1 | Polymerisation of Ethylene and Alpha-Olefins with Pyridino-Iminophenol Complexes | TOTAL PETROCHEMICALS RESEARCH FEULY (BE) | 2010-06-24 | — | — | US | disclosed |
| US-20100160583-A1 | Polymerisation of Ethylene and Alpha-Olefins with Pyridino-Iminophenol Complexes | TOTAL PETROCHEMICALS RESEARCH FEULY (BE) | 2010-06-24 | — | — | US | disclosed |
| US-20100160583-A1 | Polymerisation of Ethylene and Alpha-Olefins with Pyridino-Iminophenol Complexes | TOTAL PETROCHEMICALS RESEARCH FEULY (BE) | 2010-06-24 | — | — | US | disclosed |
| WO-2007122139-A1 | POLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS WITH PYRIDINO-IMINOPHENOL COMPLEXES | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2007-11-01 | — | — | WO | disclosed |
| EP-1849791-A1 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2007-10-31 | — | — | EP | disclosed |
| EP-1849791-A1 | Polymerisation of ethylene and alpha-olefins with pyridino-iminophenol complexes | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2007-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174507-A1 | IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF | ACSS2, ADSS2, GLS2 | HTR7 1765/4885TERT 3349/4885CCR1 3135/4885 |
| US-20250188106-A1 | SUBSTITUTED IMIDAZO[1,5-A]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME | NDC1, NUDC, PAICS | HTR7 1403/4885TERT 794/4885CCR1 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.